Found 7 matching trials
Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
EARLY_PHASE1This study is mainly assessing the safety of Revlimid in combination with A...
Location
Peter MacCallum Cancer Centre
A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
PHASE1Sickle cell anemia is a genetic disorder that results from a single nucleot...
Location
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Comparing Treatments for Multiple Myeloma
PHASE2Some drugs have the ability to push stem cells (the cells responsible for p...
Location
National Heart, Lung and Blood Institute (NHLBI)
Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer
PHASE1RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill...
Location
Roswell Park Cancer Institute
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
PHASE3This study aims to demonstrate that, in subjects with locally advanced or m...
Location
The Second Hospital Of Anhui Medical University
Stem Cell Factor Medication for Aplastic Anemia
PHASE1This trial, sponsored by Amgen, Inc., which produces the recombinant methio...
Location
National Heart, Lung and Blood Institute (NHLBI)
Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma
PHASE2Clinical Hypothesis:
It is expected that by removing chemotherapy and addi...